As most cannabis company stocks have risen in valuation over the past six months, it's worth looking at those that haven't.
A look at the charts of Advanced Micro Devices and Tesla, plus a review of the 'broadening' market action from Thursday.
The risks are likely different from what you've been told. Here's what you should be watching instead and how it could impact your investment decisions.
It could make the difference if the debt and equity markets remained thawed after a brief period of freezing.
As the debt markets sit in a moment of complacency, here's why you should check the balance sheet rundown on each stock you own.
The issue is not CHK's debt, but whether it can service the debt, and the company's robust hedge book and the recent uptrend in natural gas pricing CHK show that it should be.
But despite the recently authorized a one-time dividend of 70 cents per share, the company's debt should still sound alarm bells.
But is a Teva turnaround still coming after the stock's 70% loss in the past five years?
Brexit is not the only big issue getting kicked down the road lately.
A restructuring bill for Puerto Rico's debt passed a key vote, which increases the likelihood that it will be approved.